Clin2
NCT07528456Possibly a fitNot yet recruiting

Butylphthalide to Reduce Brain Swelling After Stroke Treatment

Acute Ischemic Stroke

Treatments studied

Part of Brain & nervous system, Heart & circulation clinical trials.

This trial tests whether a medication called butylphthalide can help reduce brain swelling that sometimes occurs after emergency endovascular treatment (a minimally invasive procedure to restore blood flow) for certain types of stroke.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
100 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You had a stroke caused by a blocked artery in your brain that was treated with endovascular intervention within the last 24 hours
  • The blood vessel was successfully reopened during the procedure
  • Your stroke was moderate to severe (based on standard neurological assessments)
  • You were not significantly disabled before your stroke
  • Your kidneys and liver are working reasonably well
  • You have not had recent bleeding in the brain or other serious brain conditions

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06663631Recruiting· Phase 1
Hibernation-like therapy for stroke recovery after clot removal

This trial tests if a hibernation-like therapy can improve recovery after a stroke caused by a large blood clot in the brain. It is for people who are having a stroke and are scheduled for a procedure to remove the clot.

Linyi, Shandong
NCT07141303Recruiting· Phase 3
Steroid after stroke clot removal for anterior circulation large vessel occlusion

This trial tests if giving a steroid (methylprednisolone) directly into the brain artery after successful clot removal improves recovery. It is for people who had a large stroke in the front part of the brain and got the clot out within 24 hours.

Xi'an, Shaanxi
NCT06226805Recruiting· Phase 2
Testing BB-031 for recent ischemic stroke

This study tests an experimental drug called BB-031 to see if it can safely help people who have had a recent ischemic stroke (a clot that blocks blood flow to the brain). The trial is for people who can get to the hospital within 24 hours of their first symptoms and have a moderate to severe stroke.

Scottsdale, Arizona
NCT06677970Recruiting· Phase 3
Blood Pressure Control After Stroke Thrombectomy

This trial tests whether carefully lowering blood pressure after a mechanical clot removal procedure for stroke can improve outcomes. If you've had a large vessel stroke that was successfully treated with thrombectomy, this study will help guide blood pressure management in the recovery period.

Seoul, Seoul
NCT07364344Not yet recruiting
Safety of hibernation-like therapy for acute stroke patients receiving clot removal

This trial tests whether a combination of two medicines (chlorpromazine and promethazine) can safely induce a hibernation-like state in people having a severe stroke caused by a large clot in the front part of the brain. Participants will receive this therapy along with standard clot removal procedures to see if it helps protect the brain.

NCT06331494Not yet recruiting
Testing butylphthalide for blocked brain arteries

This trial tests if butylphthalide, a drug that may improve blood flow, helps people with a narrowed artery in the brain (the middle cerebral artery) after a recent stroke or mini-stroke. It is for people aged 55-75 with at least one risk factor like high blood pressure or diabetes.

Guangzhou, Guangdong

Hear when a new Acute Ischemic Stroke trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.